SFX by Ex Libris Inc.

Title:	Peroxisome Proliferator–Activated Receptor γ and Metabolic Disease
Source:	Annual Review of Biochemistry [0066-4154] Willson, Timothy yr:2001

Basic

Full text

Full text available via Annual Reviews

Year:

Volume:

Issue:

Start Page:

Full text available via Annual Reviews Back Volume Collection

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Charlton, Michael R R. "Impact of obesity on treatment of chronic hepatitis C." Hepatology 43.6 (2006): 1177-86.
description	2.	Clapham, J C C. "Anti-obesity drugs: a critical review of current therapies and future opportunities." Pharmacology & therapeutics 89.1 (2000): 81-121.
description	3.	Waugh, J. "Pioglitazone: A review of its use in type 2 diabetes mellitus." Drugs 66.1 (2006): 85-109.
description	4.	Picard, F. "PPAR(gamma) and glucose homeostasis." Annual review of nutrition 22 (2002): 167-97.
description	5.	Turley, Shannon J J. "Dendritic cells: inciting and inhibiting autoimmunity." Current opinion in immunology 14.6 (2002): 765-770.
description	6.	Bays, Harold E. "Current and investigational antiobesity agents and obesity therapeutic treatment targets." Obesity 12.8 (2004): 1197-1211.
description	7.	Wahed, Abdus S S. "Race, insulin resistance and hepatic steatosis in chronic hepatitis C." Hepatology 45.1 (2006): 80-7.
description	8.	Landsberg, L. "Obesity-related hypertension: Pathogenesis, cardiovascular risk, and treatment-A position paper of the The Obesity Society and the American Society of Hypertension." Obesity 21.1 (2012): 8-24.
description	9.	Ong, Chi L L. "Low TRBP levels support an innate human immunodeficiency virus type 1 resistance in astrocytes by enhancing the PKR antiviral response." Journal of virology 79.20 (2005): 12763-72.
description	10.	Cousin, B. "Adipose tissues display differential phagocytic and microbicidal activities depending on their localization." International Journal of Obesity 25.9 (2001): 1275-1280.
description	11.	Fajas, L. "Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis." Journal of molecular endocrinology 27.1 (2001): 1-9.
description	12.	MacDougald, Susanne A. "Adipogenesis: forces that tip the scales." Trends in Endocrinology and Metabolism 13.1 (2002): 5-11.
description	13.	Antonio Barbosa, Ghulam J. "Efficacy and safety of rosiglitazone plus metformin in Mexicans with type 2 diabetes." Diabetes/metabolism research and reviews 18.2 (2002): 127-34.
description	14.	Turley, S J J. "Transport of peptide-MHC class II complexes in developing dendritic cells." Science 288.5465 (2000): 522-7.
description	15.	Hales, CN. "The thrifty phenotype hypothesis Type 2 diabetes." British Medical Bulletin 60.1 (2001): 5-.
description	16.	Redondo, M.J. J. "Genetic control of autoimmunity in Type I diabetes and associated disorders." Diabetologia 45.5 (2002): 605-622.
description	17.	Romero-Gómez, M. "Hepatitis C and insulin resistance: steatosis, fibrosis and non-response." REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS 98.8 (2006): 605-15.
description	18.	Turley, S. "Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model." The Journal of experimental medicine 198.10 (2003): 1527-37.
description	19.	Fonseca, Vivian A A. "Diabetes treatments have differential effects on nontraditional cardiovascular risk factors." Journal of diabetes and its complications 20.1 (2006): 14-20.
description	20.	Hoebe, K. "Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways." Nature immunology 4.12 (2004): 1223-9.